Rosaura Esteve-Puig, PhD
|School||UCSF School of Medicine|
|Address||555 Mission Bay Blvd South|
San Francisco CA 94158
|University of California San Francisco||Postdoctoral Researcher||Helen Diller Family Comprehensive Cancer Center. Dermatology Department||2012|
|University of Barcelona||PhD in Biomedicine. Thesis title: New evasion mechanism to metabolic stress in melanoma||University of Barcelona- Faculty of Biology||2011|
|University of Barcelona||Master's Degree, Biological and Biomedical Sciences||University of Barcelona. Faculty of Biology -Department of Biochemistry and Molecular Biology||2007|
|Vall d'Hebron Institute of Research||PhD student||University of Barcelona/Vall d'Hebron Institute of Research- Animal Model and Cancer Research||2006|
|Vall d'Hebron Institute of Oncology||Postgraduate Researcher||Growth Factors Laboratory||2005|
|University of Barcelona||Bachelor of Science in Biology Degree||University of Barcelona. Faculty of Biology||2004|
|University of Barcelona||Graduate Student Researcher||University of Barcelona. Faculty of Biology -Department of Cell Biology||2002|
Rosaura Esteve-Puig, PhD, a Postdoctoral researcher specializing in melanoma since 2005.
Pursuing an understanding of tumor molecular mechanisms for the purpose of revealing novel clinical therapies.
Expert in signal transduction, molecular and cell biology of cancer with a broad range of techniques experience such as the recently emerged CRISPR/CAS9 system, RNA-protein interactome studies, esiRNA/shRNA technology and molecular cloning.
Contributed to unveiling the missing pieces in UV-induced DNA damage response pathway; revealing a novel mechanism for the modulation of the ERK pathway signaling by methylation; proposing a new metabolic clinical approach in cancer; and identifying and characterizing new kinase fusions in spitzoid melanomas.
Cancer, Tranlational Medicine, Signal Transduction, Cancer Cell Signaling, RAS pathway, Cancer Metabolism, noncoding RNA, Mechanisms of Cancer Drug Resistance, Tumor Biology, DNA Damage, CRISPR/CAS9-Targeted genome editing, RNA-protein interactome studies
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.